Semiquantitative Gallium Scintigraphy in Patients with Osteogenic Sarcoma
- 1 April 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 9 (4) , 175-183
- https://doi.org/10.1097/00003072-198404000-00001
Abstract
Sequential gallium scans were performed in 37 patients with newly diagnosed osteogenic sarcoma. High gallium uptake was found more often in males in the 10 to 19 age group and in femoral lesions. High uptake was also seen in patients who had predominantly osteoblastic or mixed changes on radiographs and in those who had a soft tissue mass. Following chemotherapy, significant decrease of tumor to nontumor ratio occurred in the patients who responded to treatment as shown by a Grade III or IV response on histologic examinations at the time of en bloc resection. It is concluded that semiquantitative gallium scintigraphy is useful in monitoring therapeutic response in patients with osteogenic sarcoma.This publication has 7 references indexed in Scilit:
- Radiation absorbed-dose estimates for the liver, spleen, and metaphyseal growth complexes in children undergoing gallium-67 citrate scanning.Radiology, 1983
- Radionuclide bone scanning of osteosarcoma: falsely extended uptake patternsAmerican Journal of Roentgenology, 1982
- Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients.Radiology, 1982
- Quotient imaging with N- 13 L-glutamate in osteogenic sarcoma: Correlation with tumor viabilityCancer, 1981
- The indications for and limitations of bone scintigraphy in osteogenic sarcoma: A review of 55 patientsCancer, 1981
- Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.Journal of Bone and Joint Surgery, 1980
- STUDIES OF RADIOGALLIUM AS A DIAGNOSTIC AGENT IN BONE TUMORS1951